Severe primary hyperparathyroidism masked by asymptomatic celiac disease

Endocrine Practice

Volumn 14, Issue 3, 2008, Pages 347-350

  Alzahrani, Ali S ^a   Al Sheef, Mohamed ^a  

^a KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITRIOL; CALCIUM CARBONATE; ERGOCALCIFEROL; LEVOTHYROXINE; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; PARATHYROID HORMONE; CALCIUM;

ADULT; ARTICLE; BONE MASS; CASE REPORT; CELIAC DISEASE; CLINICAL FEATURE; DUODENUM BIOPSY; FEMALE; GLUTEN FREE DIET; HASHIMOTO DISEASE; HUMAN; HUMAN TISSUE; HYPERPARATHYROIDISM; HYPOTHYROIDISM; LABORATORY TEST; MALABSORPTION; PARATHYROID ADENOMA; PARATHYROID SCINTISCANNING; PARATHYROIDECTOMY; PHYSICAL EXAMINATION; VITAMIN D DEFICIENCY; BLOOD; DIFFERENTIAL DIAGNOSIS; FRACTURE; HOSPITALIZATION; PRIMARY HYPERPARATHYROIDISM;

ADULT; CALCIUM; CELIAC DISEASE; DIAGNOSIS, DIFFERENTIAL; FEMALE; FRACTURES, BONE; HUMANS; HYPERPARATHYROIDISM, PRIMARY; SEVERITY OF ILLNESS INDEX; VITAMIN D DEFICIENCY;

EID: 48949097338     PISSN: 1530891X     EISSN: None     Source Type: Journal    
DOI: 10.4158/EP.14.3.347     Document Type: Article

References (23)

1. Not T, Horvath K, Hill ID, et al. Celiac disease risk in the USA: high prevalence of antiendomysium antibodies in healthy blood donors. Scand J Gastroenterol. 1998;33: 494-498.
2. Kamin DS, Furuta GT. The iceberg cometh: establishing the prevalence of celiac disease in the United States and Finland. Gastroenterology. 2004;126:359-361.
3. Cronin CC, Feighery A, Ferriss JB, Liddy C, Shanahan F, Feighery C. High prevalence of celiac disease among patients with insulin-dependent (type I) diabetes mellitus. Am J Gastroenterol. 1997;92:2210-2212.
4. Counsell CE, Taha A, Ruddell WS. Coeliac disease and autoimmune thyroid disease. Gut. 1994;35:844-846.
5. Maida MJ, Parveen E, Crimmins SR, Swift GL. Coeliac disease and primary hyperparathyroidism: an association? Postgrad Med J. 2006;82:833-835.
6. Dent CE, Jones PE, Mullan DP. Masked primary (or tertiary) hyperparathyroidism. Lancet. 1975;1:1161-1164.
7. Gannage MH, Abikaram G, Nasr F, Awada H. Osteomalacia secondary to celiac disease, primary hyperparathyroidism, and Graves' disease. Am J Med Sci. 1998; 315:136-139.
8. Rickels MR, Mandel SJ. Celiac disease manifesting as isolated hypocalcemia. Endocr Pract. 2004;10:203-207.
9. Kavak US, Yüce A, Koçak N, et al. Bone mineral density in children with untreated and treated celiac disease. J Pediatr Gastroenterol Nutr. 2003;37:434-436.
10. Lundgren E, Hagström EG, Lundin J, et al. Primary hyperparathyroidism revisited in menopausal women with serum calcium in the upper normal range at populationbased screening 8 years ago. World J Surg. 2002;26:931-936.
11. Silverberg SJ, Bilezikian JP. "Incipient" primary hyperparathyroidism: a "forme fruste" of an old disease. J Clin Endocrinol Metab. 2003;88:5348-5352.
12. Lowe H, McMahon DJ, Rubin MR, Bilezikian JP, Silverberg SJ. Normocalcemic primary hyperparathyroidism: further characterization of a new clinical phenotype. J Clin Endocrinol Metab. 2007;92:3001-3005.
13. Lips P. Vitamin D physiology. Prog Biophys Mol Biol. 2006;92:4-8.
14. Maruani G, Hertig A, Paillard M, Houillier P. Normocalcemic primary hyperparathyroidism: evidence for a generalized target-tissue resistance to parathyroid hormone. J Clin Endocrinol Metab. 2003;88:4641-4648.
15. Krause MW, Hedinger CE. Pathologic study of parathyroid glands in tertiary hyperparathyroidism. Hum Pathol. 1985;16:772-784.
16. Seshadri MS, Qurttom MA, Sivanandan R, et al. Tertiary hyperparathyroidism in nutritional osteomalacia [letter]. Postgrad Med J. 1994;70:595-596.
17. Catassi C, Rätsch IM, Fabiani E, et al. Coeliac disease in the year 2000: exploring the iceberg. Lancet. 1994;343: 200-203.
18. Ben Hariz M, Kallel-Sellami M, Kallel L, et al. Prevalence of celiac disease in Tunisia: mass-screening study in schoolchildren. Eur J Gastroenterol Hepatol. 2007;19:687-694.
19. Kemppainen T, Kröger H, Janatuinen E, et al. Osteoporosis in adult patients with celiac disease. Bone. 1999;24:249-255.
20. Mustalahti K, Collin P, Sievänen H, Salmi J, Mäki M. Osteopenia in patients with clinically silent coeliac disease warrants screening. Lancet. 1999;354:744-745.
21. Bottaro G, Cataldo F, Rotolo N, Spina M, Corazza GR. The clinical pattern of subclinical/silent celiac disease: an analysis on 1026 consecutive cases. Am J Gastroenterol. 1999;94:691-696.
22. Selby PL, Davies M, Adams JE, Mawer EB. Bone loss in celiac disease is related to secondary hyperparathyroidism. J Bone Miner Res. 1999;14:652-657.
23. Fickling WE, McFarlane XA, Bhalla AK, Robertson DA. The clinical impact of metabolic bone disease in coeliac disease. Postgrad Med J. 2001;77:33-36.